Review

Generation of Insulin-Producing Cells From Pluripotent Stem Cells: From the Selection of Cell Sources to the Optimization of Protocols

Chee-Gee Liew

Manuscript submitted July 4, 2010; resubmitted August 2, 2010; accepted August 4, 2010.

Keywords: stem cell, induced pluripotent, embryonic, transcription factor, definite endoderm, blastocyst, endocrine pancreas, brachyury, goosecoid, gene expression

Abstract

The pancreas arises from Pdx1-expressing progenitors in developing foregut endoderm in early embryo. Expression of Ngn3 and NeuroD1 commits the cells to form endocrine pancreas, and to differentiate into subsets of cells that constitute islets of Langerhans. β-cells in the islets transcribe gene-encoding insulin, and subsequently process and secrete insulin, in response to circulating glucose. Dysfunction of β-cells has profound metabolic consequences leading to hyperglycemia and diabetes mellitus. β-cells are destroyed via autoimmune reaction in type 1 diabetes (T1D). Type 2 diabetes (T2D), characterized by impaired β-cell functions and reduced insulin sensitivity, accounts for 90% of all diabetic patients. Islet transplantation is a promising treatment for T1D. Pluripotent stem cells provide an unlimited cell source to generate new β-cells for patients with T1D. Furthermore, derivation of induced pluripotent stem cells (iPSCs) from patients captures "disease-in-a-dish" for autologous cell replacement therapy, disease modeling, and drug screening for both types of diabetes. This review highlights essential steps in pancreas development, and potential stem cell applications in cell regeneration therapy for diabetes mellitus.

Fulltext: HTML , PDF (430KB)

This article has been cited by other articles:

	Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives Berezin AE World J Diabetes 2014. 5(6):777-786
	MiRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells Lahmy R, Soleimani M, Sanati MH, Behmanesh M, Kouhkan F, Mobarra N Mol Biol Rep 2014. 41(4):2055-2066
	Generation of insulin-producing cells from rat mesenchymal stem cells using an aminopyrrole derivative XW4.4 Ouyang J, Huang W, Yu W, Xiong W, Mula RV, Zou H, Yu Y Chem Biol Interact 2014. 208:1-7
	Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors Bhonde RR, Sheshadri P, Sharma S, Kumar A Int J Biochem Cell Biol 2014. 46:90-102
	Influences of the diabetes surgery on pancreatic β-cells mass Martinez-Moreno JM, Garciacaballero M Nutr Hosp 2013. 28(Suppl 2):88-94
	Pancreatic islet differentiation of human embryonic stem cells by microRNA overexpression Lahmy R, Soleimani M, Sanati MH, Behmanesh M, Kouhkan F, Mobarra N J Tissue Eng Regen Med 2013. In press
	MicroRNAs as pharmacological targets in diabetes Mao Y, Mohan R, Zhang S, Tang X Pharmacol Res 2013. 75:37-47
	Differentiation of the definitive endoderm from Wharton's Jelly Mesenchymal Stem Cells (WJMSC) Allahbakhshi E, Bijan Nejad D, Shariati M, Tabendeh MR, Nezhad Dehbashi F, Hashemitabar M J Biol Res (Thessaloniki) 2013. 20:217-227
	The clinical and basic research of islet transplantation: A literature data analysis based on the Science Citation Index database Cao XK, Liu SQ, Li R, Liu BL Chin J Tissue Engin Res 2012. 16(18):3365-3374
	Oligodeoxynucleotide IMT504: lack of effect on immune parameters during islet regeneration in single dose streptozotocin-induced diabetes Bianchi MS, Calvo V, Chasseing NA, Lago N, Libertun C, Montaner AD, Lux-Lantos VA Diabetes Metab Res Rev 2012. 28(2):156-163
	Effect of transcription factors on differentiation into insulin-producing cells from stem cells Chen T, Qi H, Li FR Chin Bull Life Sci 2012. 24(2):145-149
	Position Statement of the Chinese Diabetes Society regarding stem cell therapy for diabetes Zhu D, Chen L, Hong T J Diabetes 2012. 4(1):18-21
	Stem cell-based immunomodulation in type 1 diabetes: beyond the regenerative approach Longoni B, Mosca F Curr Pharm Des 2011. 17(29):3229-3242
	Stem cell therapy in diabetes mellitus: current trends Sarath R, Rani VL Int J Biomed Res 2011. 2(12):608-617
	Pluripotent stem cells Müller T, Blasczyk R Tumor Diagn Ther 2011. 32(6):338-344